Physician profile
Richard Bennett
NPI 1780672238
$582.28
in general payments reported to CMS, 2019-2025
13 companies · $244 in 2025
The $244 reported for 2025 was more than what 79% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $169 · 2021: $14.48 · 2022: $75.00 · 2023: $39.09 · 2024: $40.59 · 2025: $244.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $324.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $324.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $117.52 | 2023-2025 | |
| Pfizer INC. | $80.57 | 2019-2023 | |
| Cranial Technologies, INC | $78.04 | 2019-2024 | Doc Band |
| Sanofi-Aventis U.S. LLC | $51.41 | 2025 | |
| Tris Pharma INC | $48.90 | 2019 | |
| Cipher Pharmaceuticals US LLC | $42.86 | 2025 | Spinosad, Natroba |
| Merck Sharp & Dohme LLC | $37.07 | 2022 | |
| Organon LLC | $27.11 | 2025 | |
| Abbvie INC. | $24.80 | 2022 | |
| Collegium Pharmaceutical, INC. | $21.21 | 2025 | Jornay Pm |
| Stryker Corporation | $19.62 | 2025 | Flowsaver |
| Sobi, INC | $18.39 | 2019 | |
| Shire North American Group INC | $14.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Bennett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.